Maravai LifeSciences MRVI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 3.25 | 111.60 | -0.24 | -22,529 | -36 | |
| 2025Q3 | 2.87 | 107.12 | -0.18 | -41,031 | -26 | |
| 2025Q2 | 2.41 | 98.47 | -0.27 | -66,278 | -40 | |
| 2025Q1 | 2.21 | 107.08 | -0.21 | -49,162 | -30 | |
| 2024Q4 | 5.45 | 108.30 | -0.18 | -37,702 | -26 | |
| 2024Q3 | 8.31 | 104.38 | -0.72 | -169,114 | -99 | |
| 2024Q2 | 7.16 | 190.70 | -0.06 | -9,512 | -8 | |
| 2024Q1 | 8.67 | 163.37 | -0.09 | -18,861 | -12 | |
| 2023Q4 | 6.55 | -1.06 | 67.00 | -0.80 | -7,150 | -106 |
| 2023Q3 | 10.00 | 172.72 | 33.25 | -0.05 | -15,417 | -6 |
| 2023Q2 | 12.43 | 183.13 | 41.32 | -0.05 | -11,614 | -7 |
| 2023Q1 | 14.01 | 34.65 | 12.02 | 0.00 | 2,533 | 0 |
| 2022Q4 | 14.31 | 103.01 | 7.90 | 0.30 | 109,246 | 38 |
| 2022Q3 | 25.53 | 100.00 | 13.55 | 0.34 | 116,903 | 44 |
| 2022Q2 | 28.41 | 100.71 | 16.55 | 0.53 | 180,701 | 71 |
| 2022Q1 | 35.27 | 98.74 | 25.48 | 0.50 | 167,366 | 67 |
| 2021Q4 | 41.90 | 101.87 | 0.43 | 154,541 | 56 | |
| 2021Q3 | 49.08 | 91.60 | 0.44 | 158,836 | 54 | |
| 2021Q2 | 41.73 | 100.00 | 0.45 | 155,498 | 49 | |
| 2021Q1 | 35.64 | 94.01 | 0.24 | 92,442 | 23 |